Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade

Pauken, Kristen E., Sammons, Morgan A., Odorizzi, Pamela M., Manne, Sasikanth, Godec, Jernej, Khan, Omar, Drake, Adam M., Chen, Zeyu, Sen, Debattama R., Kurachi, Makoto, Barnitz, R. Anthony, Bartman, Caroline, Bengsch, Bertram, Huang, Alexander C., Schenkel, Jason M., Vahedi, Golnaz, Haining, W. Nicholas, Berger, Shelley L., Wherry, E. John·2016·Science

DOI 10.1126/science.aaf2807

Cited by (1,000)

Items 301–400 of 1,000

Combination anti–PD-1 and antiretroviral therapy provides therapeutic benefit against SIV
Geetha Mylvaganam, Lynette S. Chea, Gregory K. Tharp, Sakeenah L. Hicks, Vijayakumar Velu, Smita Swaminathan Iyer, Claire Deléage, Jacob D. Estes, Steven E. Bosinger, Gordon James Freeman et al. · 2018 · JCI Insight
The critical role of Toll-like receptor-mediated signaling in cancer immunotherapy
Xue Chen, Yunxiao Zhang, Yao Shi Fu · 2022 · Medicine in Drug Discovery
Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy
Yannick Bulliard, Börje S. Andersson, Mehmet A. Baysal, Jason S. Damiano, Apostolia Maria Tsimberidou · 2023 · Journal of Hematology & Oncology
Marked Global DNA Hypomethylation Is Associated with Constitutive PD-L1 Expression in Melanoma
Aniruddha Chatterjee, Euan James Rodger, Antonio Ahn, Peter A. Stockwell, Matthew F. Parry, Jyoti Motwani, Stuart J. Gallagher, Elena Shklovskaya, Jessamy C. Tiffen, Michael Roger Eccles et al. · 2018 · iScience
Single-cell immune signature for detecting early-stage HCC and early assessing anti-PD-1 immunotherapy efficacy
Jiawei Shi, Junwei Liu, Xiaoxuan Tu, Bin Li, Zhou Tong, Tian Wang, Yi Zheng, Hongyu Shi, Xun Zeng, Wei Chen et al. · 2022 · Journal for ImmunoTherapy of Cancer
Beyond Cell Death: New Functions for TNF Family Cytokines in Autoimmunity and Tumor Immunotherapy
Fei Yi, Nicholas Frazzette, Anthony C. Cruz, Christopher Austin Klebanoff, Richard M. Siegel · 2018 · Trends in Molecular Medicine
Combination PD-1 and PD-L1 Blockade Promotes Durable Neoantigen-Specific T Cell-Mediated Immunity in Pancreatic Ductal Adenocarcinoma
Adam L. Burrack, Ellen J. Spartz, Jackson F. Raynor, Iris Wang, Margaret A Olson, Ingunn M. Stromnes · 2019 · Cell Reports
A New Trend in Cancer Treatment: The Combination of Epigenetics and Immunotherapy
Zaoqu Liu, Yuqing Ren, Siyuan Weng, Hui Xu, Lifeng Li, Xinwei Han · 2022 · Frontiers in Immunology
Decitabine priming increases anti–PD-1 antitumor efficacy by promoting CD8+ progenitor exhausted T cell expansion in tumor models
Xiang Li, Yaru Li, Liang Dong, Yixin Chang, Xingying Zhang, Chunmeng Wang, Meixia Chen, Xiaochen Bo, Hebing Chen, Weidong Han et al. · 2023 · Journal of Clinical Investigation
Multifactorial heterogeneity of virus-specific T cells and association with the progression of human chronic hepatitis B infection
Yang Cheng, Yuan O. Zhu, Étienne Becht, Pauline Poh Kim Aw, Jinmiao Chen, Michael Poidinger, Paola Flórez de Sessions, Martin Lloyd Hibberd, Antonio Bertoletti, Seng Gee Lim et al. · 2019 · Science Immunology
The Resistance Mechanisms of Lung Cancer Immunotherapy
Fen Wang, Shubin Wang, Qing Hua Zhou · 2020 · Frontiers in Oncology
Immunotherapy resistance in non-small-cell lung cancer: From mechanism to clinical strategies
Suna Zhou, Haihua Yang · 2023 · Frontiers in Immunology
PD-1 blockade increases the self-renewal of stem-like CD8 T cells to compensate for their accelerated differentiation into effectors
Amanda L. Gill, Peter H. Wang, Judong Lee, William H. Hudson, Satomi Ando, Koichi Araki, Yinghong Hu, Andreas Wieland, Se Jin Im, Autumn A. Gavora et al. · 2023 · Science Immunology
Recent Advancements in the Mechanisms Underlying Resistance to PD-1/PD-L1 Blockade Immunotherapy
Yu Jing Yuan, Abdalla Adam, Chen Zhao, Honglei Chen · 2021 · Cancers
Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach
Miguel López de Rodas, María Villalba-Esparza, Miguel F. Sanmamed, Lieping Chen, David L. Rimm, Kurt Alex Schalper · 2025 · Nature Reviews Clinical Oncology
Integrative molecular characterisation of gallbladder cancer reveals micro-environment-associated subtypes
Chirag Nepal, Bin Zhu, Colm J. O’Rourke, Deepak Kumar Bhatt, Donghyuk Lee, Lei Song, Difei Wang, Alison L. Van Dyke, Hyoyoung Choo‐Wosoba, Zhiwei Liu et al. · 2020 · Journal of Hepatology
Immune-related adverse effects of checkpoint immunotherapy and implications for the treatment of patients with cancer and autoimmune diseases
Betul Ibis, Konstantinos Aliazis, Carol Cao, Sasitorn Yenyuwadee, Vassiliki A. Boussiotis · 2023 · Frontiers in Immunology
Emerging role of tumor-derived extracellular vesicles in T cell suppression and dysfunction in the tumor microenvironment
Feiya Ma, Jensen Vayalil, Grace Lee, Yuqi Wang, Guangyong Peng · 2021 · Journal for ImmunoTherapy of Cancer
The SWI/SNF chromatin remodeling complexes BAF and PBAF differentially regulate epigenetic transitions in exhausted CD8+ T cells
Amy E. Baxter, Hua Huang, Josephine Ruth Giles, Zeyu Chen, Jennifer E. Wu, Sydney Drury, Katherine A Tuite-Dalton, Simone L. Park, Leonel Torres, Brandon W. Simone et al. · 2023 · Immunity
Regulators of CD8+ T cell exhaustion
Qinli Sun, Chen Dong · 2025 · Nature reviews. Immunology
Chromatin dependencies in cancer and inflammation
Marazzi, Ivan, Greenbaum, Benjamin D., Low, Diana H. P., Guccione, Ernesto · 2018 · Nature Reviews Molecular Cell Biology
The Balance between CD8(+) T Cell-Mediated Clearance of AAV-Encoded Antigen in the Liver and Tolerance Is Dependent on the Vector Dose
Kumar, Sandeep R.P., Hoffman, Brad E., Terhorst, Cox, de Jong, Ype P., Herzog, Roland W. · 2017 · Molecular Therapy
Regulatory Mechanisms of Inhibitory Immune Checkpoint Receptors Expression
Nicolas Curdy, Olivia Lanvin, Camille Laurent, Jean‐Jacques Fournié, Don‐Marc Franchini · 2019 · Trends in Cell Biology
Circulating clonally expanded T cells reflect functions of tumor-infiltrating T cells
Liliana E. Lucca, Pierre‐Paul Axisa, Benjamin Y. Lu, Brian Harnett, Shlomit Jessel, Le Zhang, Khadir Raddassi, Lin Zhang, Kelly L. Olino, James E. Clune et al. · 2020 · The Journal of Experimental Medicine
The Tumor Microenvironment Factors That Promote Resistance to Immune Checkpoint Blockade Therapy
Bonnie L. Russell, Selisha Ann Sooklal, Sibusiso Tebogo Malindisa, Lembelani Jonathan Daka, Monde McMillan Ntwasa · 2021 · Frontiers in Oncology
Cellular and molecular waypoints along the path of T cell exhaustion
Xin Lan, Caitlin C. Zebley, Ben Youngblood · 2023 · Science Immunology
Targeting mitochondria: restoring the antitumor efficacy of exhausted T cells
Meiqi Yang, Shuling Zhang, Li Sun, Le‐Tian Huang, Jing Yu, Jie-Hui Zhang, Yuan Tian, Cheng‐Bo Han, Jie‐Tao Ma · 2024 · Molecular Cancer
Genetic and Epigenetic Biomarkers of Immune Checkpoint Blockade Response
Qingyang Xiao, André Nobre, Pilar Piñeiro, Miguel‐Ángel Berciano‐Guerrero, Emilio Alba, Manuel Cobo, Volker Martin Lauschke, Isabel Barragán · 2020 · Journal of Clinical Medicine
Immune Checkpoint Inhibitors in Cancer Therapy—How to Overcome Drug Resistance?
Yefang Lao, Daoming Shen, Weili Zhang, Rui He, Min Jiang · 2022 · Cancers
DNA Methylation: From Cancer Biology to Clinical Perspectives
Chen Chen, Zehua Wang, Yi Ding, Lei Wang, Siyuan Wang, Haonan Wang, Yanru Qin · 2022 · Frontiers in Bioscience-Landmark
The Transcription Factor TCF1 in T Cell Differentiation and Aging
Chulwoo Kim, Jun Jin, Cornelia M. Weyand, Jörg J. Goronzy · 2020 · International Journal of Molecular Sciences
Architects of immunity: How dendritic cells shape CD8 + T cell fate in cancer
Vidit Bhandarkar, Teresa Dinter, Stefani Spranger · 2025 · Science Immunology
Endogenous/exogenous dual-responsive nanozyme for photothermally enhanced ferroptosis-immune reciprocal synergistic tumor therapy
H W Zhang, Jiazhen Lv, Hao Wu, Yuhan He, Mengyue Li, Chunhui Wu, Dong Lv, Yiyao Liu, Hong Yang · 2025 · Science Advances
Cutting Edge: Chromatin Accessibility Programs CD8 T Cell Memory
Christopher D. Scharer, Alexander P. R. Bally, Bhanu Gandham, Jeremy M. Boss · 2017 · The Journal of Immunology
Overcoming acquired resistance to cancer immune checkpoint therapy: potential strategies based on molecular mechanisms
Bin Wang, Han Yin, Yuyu Zhang, Qin Zhao, Huanhuan Wang, Jinlong Wei, Lingbin Meng, Ying Xin, Xin Mei Jiang · 2023 · Cell & Bioscience
Beyond T cell exhaustion: TIM-3 regulation of myeloid cells
Karen Olivia Dixon, Gonzalo Fernandez Lahore, Vijay Kumar Kuchroo · 2024 · Science Immunology
Evaluation of safety and efficacy of p53MVA vaccine combined with pembrolizumab in patients with advanced solid cancers
Vincent M. Chung, Ferdynand J. Kos, Nicola R. Hardwick, Yuan Yuan, Joseph Chao, D. Li, James Ross Waisman, Minzhao Li, Kathryn Zurcher, Paul Henry Frankel et al. · 2018 · Clinical & Translational Oncology
Recharacterizing Tumor-Infiltrating Lymphocytes by Single-Cell RNA Sequencing
Lei Zhang, Zemin Zhang · 2019 · Cancer Immunology Research
Rapid in vitro generation of bona fide exhausted CD8+ T cells is accompanied by Tcf7 promotor methylation
Manzhi Zhao, Caoimhe H. Kiernan, Christopher J. Stairiker, Jennifer L. Hope, Leticia G. León, Marjan van Meurs, Inge Brouwers-Haspels, Ruben Boers, Joachim Boers, Joost H. Gribnau et al. · 2020 · PLoS Pathogens
Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia
Meghali Goswami, Gege Gui, Laura Williams Dillon, Katherine E. Lindblad, Julie Thompson, Janet Valdez, Dong‐Yun Kim, Jack Y. Ghannam, Karolyn A. Oetjen, Christin B. DeStefano et al. · 2022 · Journal for ImmunoTherapy of Cancer
Membranous and Cytoplasmic Expression of PD-L1 in Ovarian Cancer Cells
Qiu-Xia Qu, Fang Xie, Qin Miao Huang, Xueguang Zhang · 2017 · Cellular Physiology and Biochemistry
Molecular and immune correlates of TIM-3 (HAVCR2) and galectin 9 (LGALS9) mRNA expression and DNA methylation in melanoma
Tobias A.W. Holderried, Luka de Vos, Emma Bawden, Timo Jakob Vogt, Joern Dietrich, Romina Zarbl, Friedrich Bootz, Glen Kristiansen, Peter Brossart, Jennifer Landsberg et al. · 2019 · Clinical Epigenetics
Immune Aging and Immunotherapy in Cancer
Melanie Kaiser, Maria Donatella Semeraro, Markus Herrmann, Gudrun Absenger, Armin Gerger, Wilfried Renner · 2021 · International Journal of Molecular Sciences
Tonic-signaling chimeric antigen receptors drive human regulatory T cell exhaustion
Caroline Lamarche, Kirsten A. Ward‐Hartstonge, Mi Tian, David T S Lin, Qing Bo Huang, Andrew Brown, Karlie Edwards, Gherman Novakovsky, Christopher N. Qi, Michael Steffen Kobor et al. · 2023 · Proceedings of the National Academy of Sciences
Epigenetic strategies to boost CAR T cell therapy
Behnia Akbari, Navid Ghahri-Saremi, Tahereh Soltantoyeh, Jamshid Hadjati, Saba Ghassemi, Hamid Reza Mirzaei · 2021 · Molecular Therapy
Stepwise activities of mSWI/SNF family chromatin remodeling complexes direct T cell activation and exhaustion
Elena Battistello, Kimberlee Hixon, Dawn E. Comstock, Clayton K. Collings, Xufeng Chen, Javier Rodriguez-Hernaez, Soobeom Lee, Kasey S. Cervantes, Madeline M. Hinkley, Konstantinos Ntatsoulis et al. · 2023 · Molecular Cell
Domatinostat favors the immunotherapy response by modulating the tumor immune microenvironment (TIME)
Bretz, Anne Catherine, Parnitzke, Ulrike, Kronthaler, Kerstin, Dreker, Tobias, Bartz, René, Hermann, Frank, Ammendola, Astrid, Wulff, Tanja, Hamm, Svetlana · 2019 · Journal for ImmunoTherapy of Cancer
Updates on Immunotherapy and Immune Landscape in Renal Clear Cell Carcinoma
Myung‐Chul Kim, Zeng Jin, Ryan H. Kolb, Nicholas C. Borcherding, Jonathan Alexander Chatzkel, Sara Moscovita Falzarano, Weizhou Zhang · 2021 · Cancers
An early precursor CD8+ T cell that adapts to acute or chronic viral infection
Daniel Thomas McManus, Rajesh M. Valanparambil, Christopher B. Medina, Christopher D. Scharer, Donald J. McGuire, Ewelina Sobierajska, Yinghong Hu, Daniel Y. Chang, Andreas Wieland, Judong Lee et al. · 2025 · Nature
Escape from T-cell–targeting immunotherapies in acute myeloid leukemia
Jayakumar Narayanan Vadakekolathu, Sergio Rutella · 2023 · Blood
Biomarkers in Precision Cancer Immunotherapy: Promise and Challenges
William Bennion McKean, Justin C. Moser, David L. Rimm, Siwen Hu‐Lieskovan · 2020 · American Society of Clinical Oncology Educational Book
Phase 2 Trial of Nivolumab Combined With Stereotactic Body Radiation Therapy in Patients With Metastatic or Locally Advanced Inoperable Melanoma
Nora Sundahl, Teofila Seremet, Jo Van Dorpe, Bart Neyns, Liesbeth Ferdinande, Annabel Meireson, Liève Brochez, Vibeke Krüse, Piet Ost · 2019 · International Journal of Radiation Oncology*Biology*Physics
Control of chronic lymphocytic leukemia development by clonally-expanded CD8+ T-cells that undergo functional exhaustion in secondary lymphoid tissues
Bola S. Hanna, Philipp M. Roessner, Haniyeh Yazdanparast, Dolors Colomer, Elı́as Campo, Sabrina Julia Kugler, Deyan Yordanov Yosifov, Stephan Stilgenbauer, Manfred Schmidt, Richard Gabriel et al. · 2018 · Leukemia
Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective Immunotherapy
Pavlina Chuntova, Kira Downey, Bindu Hegde, Neil D. Almeida, Hideho Okada · 2019 · Frontiers in Immunology
Improved clinical outcome in a randomized phase II study of anti-PD-1 camrelizumab plus decitabine in relapsed/refractory Hodgkin lymphoma
Yang Liu, Chunmeng Wang, Xiang Li, Liang Dong, Qingming Yang, Meixia Chen, Fengxia Shi, Malcolm V. Brock, Miao Liu, Qian Mei et al. · 2021 · Journal for ImmunoTherapy of Cancer
Targeting CD96 overcomes PD-1 blockade resistance by enhancing CD8+ TIL function in cervical cancer
Yumeng Wang, Congwen Wang, Junjun Qiu, Xinyu Qu, Jing Peng, Chong Lu, Meng Zhang, Mingxing Zhang, Xingling Qi, Guiling Li et al. · 2022 · Journal for ImmunoTherapy of Cancer
Beyond the concept of cold and hot tumors for the development of novel predictive biomarkers and the rational design of immunotherapy combination
Éléonore De Guillebon, Antoine Dardenne, Antonin Saldmann, Sylvie Séguier, Thi Tran, Léa Paolini, Célèste Lebbé, Éric Tartour · 2020 · International Journal of Cancer
Tissue-resident memory CAR T cells with stem-like characteristics display enhanced efficacy against solid and liquid tumors
In-Young Jung, Estela Noguera-Ortega, Robert L. Bartoszek, Sierra M. Collins, Erik F. Williams, Megan M. Suhoski, Julie K. Jadlowsky, Gabriela Plesa, Don L. Siegel, Anne Chew et al. · 2023 · Cell Reports Medicine
Epigenetic regulation of tumor immunity
Lizhi Pang, Fei Zhou, Yang Liu, Heba A. Ali, Fatima Khan, Amy B. Heimberger, Peiwen Chen · 2024 · Journal of Clinical Investigation
Cytokine-Mediated Regulation of CD8 T-Cell Responses During Acute and Chronic Viral Infection
Masao Hashimoto, Se Jin Im, Koichi Araki, Rafi Ahmed · 2017 · Cold Spring Harbor Perspectives in Biology
Dynamic chromatin regulatory landscape of human CAR T cell exhaustion
David G. Gennert, Rachel C. Lynn, Jeffrey M. Granja, Evan W. Weber, Maxwell R. Mumbach, Yang Zhao, Zhana Duren, Elena Sotillo, William James Greenleaf, Wing Hung Wong et al. · 2021 · Proceedings of the National Academy of Sciences
An oncolytic virus delivering tumor-irrelevant bystander T cell epitopes induces anti-tumor immunity and potentiates cancer immunotherapy
Chen, Xiangyu, Zhao, Jing, Yue, Shuai, Li, Ziyu, Duan, Xiang, Lin, Yao, Yang, Yang, He, Junjian, Gao, Leiqiong, Pan, Zhiwei et al. · 2024 · Nature Cancer
Tick-TOX, it’s time for T cell exhaustion
Thomas H. Mann, Susan M. Kaech · 2019 · Nature Immunology
Immune regulation and cytotoxic T cell activation of IL-10 agonists – Preclinical and clinical experience
Martin Oft · 2019 · Seminars in Immunology
Exhausted T cells and epigenetic status
Ziqing Zeng, Feng Wei, Xiubao Ren · 2020 · Cancer Biology and Medicine
CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas
Leticia Laura Niborski, Paul Gueguen, Mengliang Ye, Allan Thiolat, Rodrigo Nalio Ramos, Pamela Caudana, Jordan Denizeau, Ludovic Colombeau, Raphaël Rodriguez, Christel Goudot et al. · 2022 · Nature Communications
Linked CD4+/CD8+ T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression
Joseph S. Dolina, Joey Lee, Spencer E. Brightman, Sara McArdle, Samantha M. Hall, Rukman R. Thota, Karla Soria Zavala, Manasa Lanka, Ashmitaa Logandha Ramamoorthy Premlal, Jason Greenbaum et al. · 2023 · Journal of Clinical Investigation
The Tumor Microenvironment in Colorectal Cancer Therapy
Leire Pedrosa, Francis María Esposito, Timothy M. Thomson, Joan Maurel · 2019 · Cancers
Rewriting History: Epigenetic Reprogramming of CD8+ T Cell Differentiation to Enhance Immunotherapy
Caitlin C. Zebley, Stephen M Gottschalk, Ben Youngblood · 2020 · Trends in Immunology
PDL1‐positive exosomes suppress antitumor immunity by inducing tumor‐specific CD8+ T cell exhaustion during metastasis
Ji Chen, Yang Song, Feng Miao, Gang Chen, Yongjun Zhu, Ning Wu, Liewen Pang, Zhiming Chen, Xiaofeng Chen · 2021 · Cancer Science
Single-cell profiling of immune cells after neoadjuvant pembrolizumab and chemotherapy in IIIA non-small cell lung cancer (NSCLC)
Xiubao Ren, Zhenzhen Hui, Jiali Zhang, Yulin Ren, XIAOLING LI, Cihui Yan, Tao Wang, Wenwen Yu, Tao Wang, Shanshan Xiao et al. · 2022 · Cell Death and Disease
Schistosomiasis Induces Persistent DNA Methylation and Tuberculosis-Specific Immune Changes
Andrew R. DiNardo, Tomoki Nishiguchi, Emily Margaret Mace, Kimal Rajapakshe, Godwin Mtetwa, Alexander W. Kay, Gugu P. Maphalala, William Evan Secor, Rojelio Mejía, Jordan Scott Orange et al. · 2018 · The Journal of Immunology
Dynamic Post-Transcriptional Events Governing CD8+ T Cell Homeostasis and Effector Function
Fiamma Salerno, Martin Turner, Monika C. Wolkers · 2020 · Trends in Immunology
On the use of immune checkpoint inhibitors in patients with viral infections including COVID-19
Thilo Gambichler, Judith Reuther, Christina Scheel, Jürgen Christian Becker · 2020 · Journal for ImmunoTherapy of Cancer
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection
Valeria Barili, Paola Fisicaro, Barbara Montanini, Greta Acerbi, Anita Filippi, Giovanna Forleo, Chiara Romualdi, Manuela Ferracin, Francesca Guerrieri, Giuseppe Pedrazzi et al. · 2020 · Nature Communications
Role of regulation of PD-1 and PD-L1 expression in sepsis
Teng Zhang, Li Yu-Jing, Tao Ma · 2023 · Frontiers in Immunology
Distinct epigenomic landscapes underlie tissue-specific memory T cell differentiation
Frank A. Buquicchio, Raíssa Fonseca, Patrick Yan, Fangyi Wang, Maximilien Evrard, Andreas Obers, Jacob C. Gutierrez, Colin J. Raposo, Julia A. Belk, Bence Dániel et al. · 2024 · Immunity
Epigenetic modulation in cancer immunotherapy
Stuart J. Gallagher, Elena Shklovskaya, Peter Hersey · 2017 · Current Opinion in Pharmacology
Epigenetic Regulation of T Cell Memory: Recalling Therapeutic Implications
David F. Tough, Inma Rioja, Louise Kelly Modis, Rab K. Prinjha · 2019 · Trends in Immunology
Unraveling exhaustion in adaptive and conventional NK cells
Aimee Marie Merino, Hansol Kim, Jeffrey S. Miller, Frank M. Cichocki · 2020 · Journal of Leukocyte Biology
Mechanisms of T cell exhaustion guiding next-generation immunotherapy
Zebley, Caitlin C., Youngblood, Ben · 2022 · Trends in Cancer
BET bromodomain inhibition rescues PD-1-mediated T-cell exhaustion in acute myeloid leukemia
Mengjun Zhong, Rili Gao, Ruocong Zhao, Youxue Huang, Cunte Chen, Kehan Li, Xibao Yu, Dingrui Nie, Zheng Chen, Xin Liu et al. · 2022 · Cell Death and Disease
The Role of CD4 T Cell Help in CD8 T Cell Differentiation and Function During Chronic Infection and Cancer
Paytsar Topchyan, Siying Lin, Weiguo Cui · 2023 · Immune Network
Decoding and overcoming T cell exhaustion: Epigenetic and transcriptional dynamics in CAR-T cells against solid tumors
Taeyoung Ahn, Eun‐Ah Bae, Hyungseok Seo · 2024 · Molecular Therapy
Activation of NKT Cells in an Anti-PD-1–Resistant Tumor Model Enhances Antitumor Immunity by Reinvigorating Exhausted CD8 T Cells
Eun‐Ah Bae, Hyungseok Seo, Byung Seok Kim, Jeong-Won Choi, Insu Jeon, Kwang-Soo Shin, Choong‐Hyun Koh, Boyeong Song, Il‐Kyu Kim, Byung Soh Min et al. · 2018 · Cancer Research
Ginseng-derived nanoparticles reprogram macrophages to regulate arginase-1 release for ameliorating T cell exhaustion in tumor microenvironment
Yan Lv, Mengyuan Li, Ling Weng, Haoying Huang, Yujie Mao, Danchen Aaron Yang, Qingyun Wei, Mengmeng Zhao, Wei Dong Qin, Ke Rui et al. · 2023 · Journal of Experimental & Clinical Cancer Research
PD-1 Blockade Promotes Epitope Spreading in Anticancer CD8+ T Cell Responses by Preventing Fratricidal Death of Subdominant Clones To Relieve Immunodomination
Arash Memarnejadian, Courtney Erin Meilleur, Christopher R. Shaler, Khashayarsha Khazaie, Jack R. Bennink, Todd D. Schell, S. M. Mansour Haeryfar · 2017 · The Journal of Immunology
PD-1 Imposes Qualitative Control of Cellular Transcriptomes in Response to T Cell Activation
Shimizu, Kenji, Sugiura, Daisuke, Okazaki, Il-mi, Maruhashi, Takumi, Takegami, Yujiro, Cheng, Chaoyang, Ozaki, Soichi, Okazaki, Taku · 2020 · Molecular Cell
Immune Responses to Retroviruses
Asier Sáez‐Cirión, Nicolas Manel · 2018 · Annual Review of Immunology
Costimulatory domains direct distinct fates of CAR-driven T cell dysfunction
Mehmet Emrah Selli, Jack H. Landmann, Marina Terekhova, John Lattin, Amanda D. Heard, Yu-Sung Hsu, Tien-Ching Chang, Jufang Chang, John M. Warrington, Helen Ha et al. · 2023 · Blood
Mechanisms of CD8+ T cell exclusion and dysfunction in cancer resistance to anti-PD-(L)1
Keywan Mortezaee, Jamal Majidpoor · 2023 · Biomedicine & Pharmacotherapy
Future of anti-PD-1/PD-L1 applications: Combinations with other therapeutic regimens
Mengjia Song, Xinfeng Chen, Liping Wang, Yi Zhang · 2018 · Chinese Journal of Cancer Research
Tumor microenvironmental influences on dendritic cell and T cell function: A focus on clinically relevant immunologic and metabolic checkpoints
Kristian Michael Hargadon · 2020 · Clinical and Translational Medicine
Exhausted CD8+ T cells face a developmental fork in the road
Ryan Zander, Weiguo Cui · 2023 · Trends in Immunology
Treatment Advances in Sepsis and Septic Shock: Modulating Pro- and Anti-Inflammatory Mechanisms
A. M. Marques, Carla Torre, Rui M. A. Pinto, Bruno Miguel Nogueira Sepodes, João Pedro Rocha · 2023 · Journal of Clinical Medicine
IGSF8 is an innate immune checkpoint and cancer immunotherapy target
Yulong Li, Xiangyang Wu, Caibin Sheng, Hailing Liu, Huizhu Liu, Yixuan Tang, Chao Liu, Qingyang Ding, Bin Xie, Xi Xiao et al. · 2024 · Cell
CD4 + T help promotes influenza virus-specific CD8 + T cell memory by limiting metabolic dysfunction
Jolie G. Cullen, Hayley A. McQuilten, Kylie M. Quinn, Moshe Olshansky, Brendan E. Russ, Alison Morey, Sanna Wei, Julia E. Prier, Nicole L. La Gruta, Peter C. Doherty et al. · 2019 · Proceedings of the National Academy of Sciences
Checkpoint Inhibitors and Therapeutic Vaccines for the Treatment of Chronic HBV Infection
Ruben C. Hoogeveen, André Boonstra · 2020 · Frontiers in Immunology
CD8 + T-Cell Memory: The Why, the When, and the How
Stephen T. Turner, Taylah J. Bennett, Nicole L. La Gruta · 2021 · Cold Spring Harbor Perspectives in Biology
Unraveling the Complexity of the Cancer Microenvironment With Multidimensional Genomic and Cytometric Technologies
Natasja L. De Vries, Ahmed Essam Mahfouz, Frits Koning, Noel F.C.C. de Miranda · 2020 · Frontiers in Oncology